101990-70-9 Usage
Description
5-(Chloromethyl)-2-methoxypyridine is an organic compound with the molecular formula C6H6ClNO2. It is a derivative of pyridine, featuring a chloromethyl group at the 5th position and a methoxy group at the 2nd position. 5-(CHLOROMETHYL)-2-METHOXYPYRIDINE serves as a key intermediate in the synthesis of various pharmaceuticals and bioactive molecules due to its unique structural properties.
Uses
Used in Pharmaceutical Industry:
5-(Chloromethyl)-2-methoxypyridine is used as a key intermediate in the synthesis of pyrazolopyridine compounds, which are known as RET kinase inhibitors. These inhibitors play a crucial role in the treatment of RET-related diseases, such as certain types of cancer and other disorders caused by abnormal RET kinase activity. The compound's unique structure allows for the development of targeted therapies with potential applications in oncology and other medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 101990-70-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,9,9 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 101990-70:
(8*1)+(7*0)+(6*1)+(5*9)+(4*9)+(3*0)+(2*7)+(1*0)=109
109 % 10 = 9
So 101990-70-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H8ClNO/c1-10-7-3-2-6(4-8)5-9-7/h2-3,5H,4H2,1H3
101990-70-9Relevant articles and documents
GPR52 MODULATOR COMPOUNDS
-
, (2021/05/15)
The disclosures herein relate to novel compounds of Formula (1): (1) and salts thereof, wherein R1, Q, X, Y and Z are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with GPR52 receptors.
MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
-
Page/Page column 41, (2018/03/25)
The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).
PROBES FOR IMAGING HUNTINGTIN PROTEIN
-
Paragraph 0259, (2016/03/22)
Provided are imaging agents comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and methods of their use.
